In the News

Relationship to serve as an extension of company’s ongoing innovation efforts in the areas of real-world research, patient-centered research, pragmatic trials and platform studies.

PPD becomes the first contract research organization to join the MIT Center for Biomedical Innovation’s New Drug Development Paradigms (NEWDIGS).

Gaurav Bhatnagar comments on how technology and data-driven approaches will be key to “bending the cost and time curve” of drug development.

Acurian’s Scott Connor notes that the most important aspect when designing any app is to create something that has a singular purpose.

Acurian and Synexus have launched a comprehensive solution for enrolling patients in clinical studies for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

The companies will combine efforts to enable trial sponsors to find, qualify and enroll NAFLD and NASH patients more effectively and efficiently.

Nik Morton and Roger Smith discuss how this new program serves as a single point of contact to help proactively guide patients through trials.

In this article, Tim Neathery notes that more people are becoming aware of the positive aspects of building a career in the clinical research space.

John Bak talks about developing appropriate tests for addressing foreign particles in orally inhaled and nasal drug products.